These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1704366)

  • 1. Evidence that type 1 plasminogen activator inhibitor binds to the somatomedin B domain of vitronectin.
    Seiffert D; Loskutoff DJ
    J Biol Chem; 1991 Feb; 266(5):2824-30. PubMed ID: 1704366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic analysis of the interaction between type 1 plasminogen activator inhibitor and vitronectin and evidence that the bovine inhibitor binds to a thrombin-derived amino-terminal fragment of bovine vitronectin.
    Seiffert D; Loskutoff DJ
    Biochim Biophys Acta; 1991 May; 1078(1):23-30. PubMed ID: 1710930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin.
    Preissner KT; Grulich-Henn J; Ehrlich HJ; Declerck P; Justus C; Collen D; Pannekoek H; Müller-Berghaus G
    J Biol Chem; 1990 Oct; 265(30):18490-8. PubMed ID: 1698787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation.
    Kost C; Stüber W; Ehrlich HJ; Pannekoek H; Preissner KT
    J Biol Chem; 1992 Jun; 267(17):12098-105. PubMed ID: 1376317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The somatomedin B domain of vitronectin. Structural requirements for the binding and stabilization of active type 1 plasminogen activator inhibitor.
    Seiffert D; Ciambrone G; Wagner NV; Binder BR; Loskutoff DJ
    J Biol Chem; 1994 Jan; 269(4):2659-66. PubMed ID: 7507927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin).
    Declerck PJ; De Mol M; Alessi MC; Baudner S; Pâques EP; Preissner KT; Müller-Berghaus G; Collen D
    J Biol Chem; 1988 Oct; 263(30):15454-61. PubMed ID: 2459123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity purification of active plasminogen activator inhibitor-1 (PAI-1) using immobilized anhydrourokinase. Demonstration of the binding, stabilization, and activation of PAI-1 by vitronectin.
    Wun TC; Palmier MO; Siegel NR; Smith CE
    J Biol Chem; 1989 May; 264(14):7862-8. PubMed ID: 2470735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional analysis of the plasminogen activator inhibitor-1 binding motif in the somatomedin B domain of vitronectin.
    Deng G; Royle G; Wang S; Crain K; Loskutoff DJ
    J Biol Chem; 1996 May; 271(22):12716-23. PubMed ID: 8662688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of plasminogen activator inhibitor type-1 to extracellular matrix of Hep G2 cells. Evidence that the binding protein is vitronectin.
    Owensby DA; Morton PA; Wun TC; Schwartz AL
    J Biol Chem; 1991 Mar; 266(7):4334-40. PubMed ID: 1705551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitronectin governs the interaction between plasminogen activator inhibitor 1 and tissue-type plasminogen activator.
    Keijer J; Ehrlich HJ; Linders M; Preissner KT; Pannekoek H
    J Biol Chem; 1991 Jun; 266(16):10700-7. PubMed ID: 1709939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The glycosaminoglycan binding site governs ligand binding to the somatomedin B domain of vitronectin.
    Seiffert D
    J Biol Chem; 1997 Apr; 272(15):9971-8. PubMed ID: 9092537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method for defining binding sites involved in protein-protein interactions: analysis of the binding of plasminogen activator inhibitor 1 to the somatomedin domain of vitronectin.
    Royle G; Deng G; Seiffert D; Loskutoff DJ
    Anal Biochem; 2001 Sep; 296(2):245-53. PubMed ID: 11554720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domain structure of vitronectin. Alignment of active sites.
    Suzuki S; Pierschbacher MD; Hayman EG; Nguyen K; Ohgren Y; Ruoslahti E
    J Biol Chem; 1984 Dec; 259(24):15307-14. PubMed ID: 6210287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional interaction of plasminogen activator inhibitor type 1 (PAI-1) and heparin.
    Ehrlich HJ; Keijer J; Preissner KT; Gebbink RK; Pannekoek H
    Biochemistry; 1991 Jan; 30(4):1021-8. PubMed ID: 1703436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor.
    Seiffert D; Wagner NN; Loskutoff DJ
    J Cell Biol; 1990 Sep; 111(3):1283-91. PubMed ID: 1697297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix.
    Ehrlich HJ; Gebbink RK; Preissner KT; Keijer J; Esmon NL; Mertens K; Pannekoek H
    J Cell Biol; 1991 Dec; 115(6):1773-81. PubMed ID: 1721912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of high and low molecular weight plasminogen activator inhibitor 1 from fibrosarcoma cell-line HT 1080 conditioned medium.
    Lindahl T; Wiman B
    Biochim Biophys Acta; 1989 Feb; 994(3):253-7. PubMed ID: 2493266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of structural requirements on plasminogen activator inhibitor 1 for binding to heparin.
    Ehrlich HJ; Gebbink RK; Keijer J; Pannekoek H
    J Biol Chem; 1992 Jun; 267(16):11606-11. PubMed ID: 1375944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin (Vn): mapping the binding sites on PAI-1 and Vn.
    Schroeck F; Arroyo de Prada N; Sperl S; Schmitt M; Viktor M
    Biol Chem; 2002; 383(7-8):1143-9. PubMed ID: 12437099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor 1 (PAI) is bound to vitronectin in plasma.
    Wiman B; Almquist A; Sigurdardottir O; Lindahl T
    FEBS Lett; 1988 Dec; 242(1):125-8. PubMed ID: 2462509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.